Skip to main content
Log in

Pharmacokinetics of pirprofen in children with juvenile chronic arthritis

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Pirprofen (100 or 200 mg; Rengasil®) was administered to experimental groups of children (children with juvenile chronic arthritis, JCA) and to a control group of children (children without JCA) as a single dose or as repeated doses. The pharmacokinetics of pirprofen in these children were compared to the pharmacokinetic parameter values obtained in healthy volunteers and in elderly arthritic adults receiving 400 mg of pirprofen.

The children were examined regularly and laboratory values were determined in order to detect possible side effects. The results demonstrated that the pharmacokinetics of pirprofen were similar for children and adults when taking into account the dose and the body weight There was no drug accumulation after repeated adrninistration of pirprofen.

As already observed in rheumatic adults, pirprofen remains in synovial fluid longer than in plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cohen M. (1982): Etude pharmacologique du pirprofène. Nouv. Presse Med., 11, 2475–2480.

    CAS  PubMed  Google Scholar 

  2. Hirtz J., Bartlett M.F. (1982): The pharmacokinetics of pirprofen. In; Van der Korst J.K. {nt(ed)}. Pirprofen in the Treatment of Pain and Inflammation. Bernm, Hans Huber, pp 16–29.

    Google Scholar 

  3. Ancill R.J. (1984): Pirprofen. A review. Drugs Today, 20, 121–130.

    Google Scholar 

  4. Wood P.H.N. (1978): Special Meeting on Nomenclature and Classification of Arthritis in children. In: Munthe E. {nt(ed)}. The Care of Rheumatic Children. Basel, Eular Publishers, pp 47–51.

    Google Scholar 

  5. Colussi D., Marfil F., Sioufi A. (1985): Simultaneous determination of pirprofen and its metabolite the pyrrole derivative in plasma by high performance liquid chromatography. J. Chromatogr. Biomed. Appl., 339, 157–162.

    Article  CAS  Google Scholar 

  6. Rooney L., Kendall M.J., Main A., Hosie J., John V.A. (1985): Pharmacokinetics of pirprofen in young volunteers and elderly patients. Eur. J. Clin. Pharmacol., 29., 73–77.

    Article  PubMed  Google Scholar 

  7. Schoeller J.P., Schwarzberg C., Gérardin A., Colussi D., Sioufi A., Hirtz J. (1983): Elimination compar ’ee du pirprofène à partir du plasma et du liquide synovial du genou. Nouv. Presse Med., 12, 2045–2047.

    CAS  Google Scholar 

  8. Mãkelã A.L., Lempiainen H., Ylijoki H. (1981): Ibuprofen levels in serum and synovial fluid. Scand. J. Rheumatol. Suppl., 39, 15–17.

    Article  PubMed  Google Scholar 

  9. Dougados M., Coste P., Stalla-Bourdillon A., Amor B. (1986): Influence de la nature de l’épanchement articulaire sur la diffusion des anti-inflammatoires non stéroidiens à travers la membrane synoviale: A propos du naproxène sodique 550 mg au cours de la polyarthrite rhumatoide et la gonarthrose. Rev. Int Rhumatol. “R” 83, 105–109.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hallé, F., Marfil, F., Sioufi, A. et al. Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. European Journal of Drug Metabolism and Pharmacokinetics 16, 29–34 (1991). https://doi.org/10.1007/BF03189871

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189871

Keywords

Navigation